Valuation (67%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 14.47 | N/A |
| PEG Ratio (TTM) | 3.01 | N/A |
| P/S Ratio (TTM) | 2.40 | N/A |
| P/B Ratio (TTM) | 1.21 | N/A |
| P/FCF Ratio (TTM) | 55.24 | N/A |
| Price to 5YR AVG Earnings Ratio | 11.69 | N/A |
| Price to 5YR AVG FCF Ratio | 12.36 | N/A |
Profitability (45%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.75% | N/A |
| ROE (TTM) | 8.60% | N/A |
| Net Profit Margin (TTM) | 16.59% | N/A |
| ROIC 5YR AVG | 21.10% | N/A |
Growth (43%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 4.85% | 9.72% | -2.25% |
| Revenue | 7.06% | 8.18% | 3.32% |
| Net Income | 3.89% | 11.45% | -1.23% |
| Cash Flow | -22.94% | 20.72% | -3.16% |
Health (37%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | N/A | N/A |
| Quick Ratio (TTM) | N/A | N/A |
| D/E Ratio (TTM) | 0.07 | N/A |
| Interest Coverage (TTM) | 3.33 | N/A |
| Piotroski F-Score | 5 | N/A |
| Altman Z-Score | 0.30 | N/A |
| LTL to 5YR AVG FCF | 1.33 | N/A |
| Shares Outstanding Growth 5YR AVG | 1.00% | N/A |